Effects of L-Acetylcarnitine on cirrhotic patients with hepatic coma: Randomized double-blind, placebo-controlled trial

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2242-2247

  Malaguarnera, Mariano ^a   Pistone, Giovanni ^a   Astuto, Marinella ^a   Vecchio, Ignazio ^a   Raffaele, Rocco ^a   Giudice, Emilia Lo ^a   Rampello, Liborio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cirrhosis; Hepatic coma; Hepatic encephalopathy; L Acetylcarnitine

Indexed keywords

ACETYLCARNITINE; AMMONIA; NOOTROPIC AGENT;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; FEMALE; GLASGOW COMA SCALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SYNAPTIC TRANSMISSION; UREA NITROGEN BLOOD LEVEL;

ACETYLCARNITINE; ADULT; AMMONIA; BLOOD UREA NITROGEN; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; GLASGOW COMA SCALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; SYNAPTIC TRANSMISSION;

EID: 33846989018     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9187-0     Document Type: Article

References (33)

1. Jones EA, Weissenborn K (1997) Neurology and the liver. JNNP 63:279-293
2. BleiAT (2000) Diagnosis and treatment of hepatic encephalopathy. Baillieres Best Pract Res Clin Gastroenterol 14:959-974
3. Licinio J,WongML(1997) Pathways andmechanisms for cytokine signalling of the central nervous system. J Clin Invest 100:2941-2947
4. Yurdaycin C,Walsh TJ, Engler HD, Ha JH, Li Y, Jones EA, Basile AS (1995) Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy. Brain Res 679:42-48
5. Zieve L, Onstad GR (1980) High brain concentration of phenylalanine, tryptophan and methionine do not cause coma in rats or dogs. Gastroenterology 79:1070
6. Norenberg MD (1996) Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 16:245-253
7. Donovan JP, Schafer DF, Shaw BW Jr, Sorrell MF (1998) Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 35:719-721
8. Malaguarnera M, Trovato BA, Pistone G, Scuderi M, Vinci M, Romano M, Marletta F (1996) Electrophysiological alterations in hepatic encephalopathy detected by brain mapping. Panminerva Med 38:84-88
9. HaussingerD,KircheisG, Fischer R, Schliess F, von Dahl S (2000) Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32:1035-1038
10. Basile AS, Jones EA (1997) Ammonia and GABAergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 25:103-105
11. Farrel L, Vogel J, Bierber LL (1986) Entry of L-acetylcarnitine into biosynthetic pathways. Biochim Biophys Acta 876:175-177
12. Siliprandi N, Siliprandi D, Ciman M (1965) Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine. Biochem J 96:777-780
13. Montgomery SA, Thal LJ, Amrein R (2003) Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 18:61-71
14. Virmani A, Binienda Z (2004) Role of carnitine esters in brain neuropathology. Mol Aspects Med 25:533-549
15. Conn HO, Lieberthal MM (1979) The hepatic coma syndromes and lactulose. Williams and Wilkins, Baltimore, pp 1-121
16. Pappas SC, Jones EA (1983) Methods for assessing hepatic encephalopathy. Semin Liver Dis 3:298-307
17. Tesdale G, Jennet B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-83
18. De Fonseca-Wollheim F (1973) Direkte plasmaammoniakbestimmung ohne Enteiweissung. Clin Chem Clin Biochem 11:421-431
19. Als-Nielsen B, Gluud LL, Gluud C (2004) Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328:1046
20. Plauth M, Raible A, Graser TA, Noldeke IL, Furst P, Dolle W, Hartmann F (1994) Lactulose or paromomycin do not affect ammonia generation in the isolated perfused rat small intestine. Z Gastroenterol 32:141-145
21. Goulenok C, Bernard B, Cadranel JF, Thabut D, Di Martino V, Opolon P, Poynard T (2002) Flumazenil vs placebo in hepatic encephalopathy in patientswith cirrhosis: a meta-analysis. Aliment Pharmacol Ther 16:361-372
22. Scollo Lavizzari G, Steinmann E (1985) Reversal of hepatic coma by benzodiazepine antagonist (RO 15-1788). Lancet 1:1324
23. Bansky G, Meier PJ, Ziegler WH, Walser H, Schmidt M, Huber M (1985) Reversal of hepatic coma by benzodiazepine antagonist (RO15-1788). Lancet 1:1324-1325
24. Pomier-Layrargues G, Giguere JF, Lavoice J, et al. (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomised double blind placebo-controlled crossover trial.Hepatology 19:32-37
25. Gyr K, Meier R, Haussler J, et al. (1996) Evaluation of efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: double-blind, randomised, placebo-controlled multicentre study. Gut 39:319-324
26. Clouet P, Sempore G, Tsoko M, Gresti J, Demarquoy J, Niot I, Bezard J, Martin-Privat P (1996) Effect of short- and long-term treatments by a low level of dietary L-carnitine on parameters related to fatty acid oxidation inWistar rat. Biochim Biophys Acta 1299:191-197
27. Ahern DA, Mitchell ME (1989) Liver function in protein-energy malnutritionmeasured by cinnamic acid tolerance and benzoic acid tolerance: effect of carnitine supplementation. Br J Nutr 61:209-221
28. Therrien G, Rose C, Butterworth J, Butterworth RF (1997) Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portocaval shunted rat. Hepatology 25:551-556
29. O'Connor JE, Costell M, Grisolia S (1984) Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain. Neurochem Res 9:563-570
30. Malaguarnera M, Pistone G, Astuto M, Dell'Arte S, Finocchiaro G, Lo Giudice E, Pennisi G (2003) L-Carnitine in the treatment of mild or moderate hepatic encephalopathy. Dig Dis 21:271-275
31. Malaguarnera M, Pistone G, Rampello E, Leotta C, Scarpello L, Rampello L (2005) Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 11:7197-7202
32. McCandless DW, Schenker S (1981) Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. J Neurochem 44:325-330
33. Cooper AJL, Mora SN, Cruz NF, Gelbard AS (1985) Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 44:1716-1723